NashBio's Whole Genome Sequencing Webinar

Leveraging Whole-Genome Sequencing for Advanced Drug Discovery

Wednesday, October 23rd
11:00 am Eastern Time

The current whole-genome sequence (WGS) data has revolutionized views on drug
discovery and shed new light on the cutting edge of pharmaceutical development. As
drugs supported by genetic evidence show significantly higher success rates, large
genomic datasets become essential for enabling this level of screening. Massively
scaled WGS is likely to become increasingly important, as it provides a far more
comprehensive view of the genome-extending beyond protein-coding regions to include
regulatory elements, copy number variants, and much more.

We explore the transformative potential of real-world clinico-genomic data, which offers
valuable disease context and longitudinal depth often missing in traditional population
biobanks.

Key Takeaways

• Understanding the Impact of Whole-Genome Sequencing: Learn how WGS
  provides a complete genetic picture, crucial for identifying viable drug targets and
  understanding complex genetic interactions.
• Discuss why robust discovery depends on large-scale genomic datasets and
  what this scale means for future research.
• Translating Genetic Insights into Clinical Success: Explore how integrating
  detailed genetic data with clinical insights can dramatically improve the success
  rate of new drug candidates while streamlining the pipeline from discovery to
  development.

Join us as we explore how the complexity of genomic data is driving the next generation
of pharmaceutical breakthroughs and enabling the development of more targeted and
effective therapies. This session is important for industry professionals eager to
leverage genetic research to optimize drug development in a highly competitive
landscape.

Speakers To Be Announced. Registration Opens Soon!